Related Experiment Video
Updated: Mar 22, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
Cystatin E/M Suppresses Tumor Cell Growth through Cytoplasmic Retention of NF-κB
Hendrick Soh1, Natarajan Venkatesan1, Mysore S Veena2
1Division of General Surgery, Department of Surgery, VAGLAHS/David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Abstract:
We and others have shown that the cystatin E/M gene is inactivated in primary human tumors, pointing to its role as a tumor suppressor gene. However, the molecular mechanism of tumor suppression is not yet understood. Using plasmid-directed cystatin E/M gene overexpression, a lentivirus-mediated tetracycline-inducible vector system, and human papillomavirus 16 (HPV 16) E6 and E7 gene-immortalized normal human epidermal keratinocytes, we demonstrated intracellular and non-cell-autonomous apoptotic growth inhibition of tumor cell lines and that growth inhibition is associated with cytoplasmic retention of NF-κB. We further demonstrated decreased phosphorylation of IκB kinase (IKKβ) and IκBα in the presence of tumor necrosis factor alpha (TNF-α), confirming the role of cystatin E/M in the regulation of the NF-κB signaling pathway. Growth suppression of nude mouse xenograft tumors carrying a tetracycline-inducible vector system was observed with the addition of doxycycline in drinking water, confirming that the cystatin E/M gene is a tumor suppressor gene. Finally, immunohistochemical analyses of cervical carcinoma in situ and primary tumors have shown a statistically significant inverse relationship between the expression of cystatin E/M and cathepsin L and a direct relationship between the loss of cystatin E/M expression and nuclear expression of NF-κB. We therefore propose that the cystatin E/M suppressor gene plays an important role in the regulation of NF-κB.
Insights
The cystatin E/M gene acts as a tumor suppressor by inhibiting cancer cell growth. Its mechanism involves regulating the NF-κB pathway, with reduced expression linked to tumor progression.
Area of Science:
- Molecular biology
- Cancer research
- Genetics
Background:
- Cystatin E/M gene inactivation in human tumors suggests a tumor suppressor role.
- The precise molecular mechanism of cystatin E/M tumor suppression remains unclear.
Purpose of the Study:
- To elucidate the molecular mechanism of cystatin E/M-mediated tumor suppression.
- To investigate the role of cystatin E/M in regulating the NF-κB signaling pathway.
Main Methods:
- Overexpression of cystatin E/M using plasmid and lentiviral vectors in keratinocytes.
- Analysis of NF-κB pathway components (NF-κB, IKKβ, IκBα) and tumor necrosis factor alpha (TNF-α) signaling.
- In vivo studies using nude mouse xenografts and immunohistochemical analysis of tumor tissues.
Main Results:
- Cystatin E/M overexpression induced apoptotic growth inhibition in tumor cell lines.
- Growth inhibition correlated with cytoplasmic retention of NF-κB and decreased IκBα phosphorylation.
- In vivo tumor growth suppression was observed with doxycycline-induced cystatin E/M expression.
- Inverse correlation between cystatin E/M and cathepsin L expression, and direct correlation with nuclear NF-κB in cervical cancers.
Conclusions:
- Cystatin E/M functions as a tumor suppressor gene.
- Cystatin E/M regulates tumor growth and apoptosis through the NF-κB signaling pathway.
- Loss of cystatin E/M expression is associated with tumor progression and nuclear NF-κB accumulation.
Related Concept Videos
Abnormal Proliferation
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Mitogens and the Cell Cycle
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Regulation of Nuclear Protein Sorting
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...

